“Patients no longer want a single treatment that attempts to address everything, and rightly so because that doesn’t exist.

Biologics growth and resilient GLP-1 demand support long-term earnings after a 14% pullback; see margin outlook, 2026 profit ...

Ocugen's stock has opened the 2026 trading year on a positive note. The absence of fresh corporate announcements has shifted focus to the company's clinical development pipeline, with investor ...

Women like J.K. Rowling, who dare to suggest that biological sex exists and matters, are now vilified by the very feminists ...

Huntington's Disease burdens caregivers in India, facing financial strain and limited support amid widespread underdiagnosis ...

Every year, January opens the year and tends to feel like a clean slate for you to cast your most ambitious goals and wildest ...

Why is the Indore water contamination issue important for your UPSC exam? What significance do topics such as the methane, ...